TELA Bio, Inc.TELANASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
6.58%
↑ 18% above average
Average (30q)
5.58%
Historical baseline
Range
High:78.49%
Low:-51.09%
Volatility
2321.1%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 6.58% |
| Q2 2025 | -13.27% |
| Q1 2025 | 25.18% |
| Q4 2024 | -1.89% |
| Q3 2024 | -10.98% |
| Q2 2024 | -2.93% |
| Q1 2024 | -10.88% |
| Q4 2023 | 13.39% |
| Q3 2023 | -5.81% |
| Q2 2023 | 22.51% |
| Q1 2023 | -24.72% |
| Q4 2022 | 29.69% |
| Q3 2022 | 0.00% |
| Q2 2022 | 4.73% |
| Q1 2022 | 16.35% |
| Q4 2021 | 22.43% |
| Q3 2021 | -26.99% |
| Q2 2021 | 14.95% |
| Q1 2021 | 44.37% |
| Q4 2020 | -3.16% |
| Q3 2020 | 22.68% |
| Q2 2020 | 7.35% |
| Q1 2020 | -0.98% |
| Q4 2019 | 78.49% |
| Q3 2019 | -51.09% |
| Q2 2019 | -36.41% |
| Q1 2019 | 69.81% |
| Q4 2018 | -6.42% |
| Q3 2018 | -9.92% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |